Atlas Trials

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Clinical trial NCT04217148 · COMPLETED

Trial details

NCT number
NCT04217148
Sponsor
Peking University People's Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2020-01-01
Primary completion
2020-06-30
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.